AIDS vaccine may offer hope only for some ethnic groupsBMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7387.463 (Published 01 March 2003) Cite this as: BMJ 2003;326:463
- Lynn Eaton
An AIDS vaccine, which has been in phase III trials for the past three years, has failed to show a significant reduction in the development of HIV among the those who were vaccinated, the manufacturer, VaxGen, has announced.
But the vaccine has shown a significant reduction in certain ethnic groups, indicating that black and Asian volunteers may have produced higher levels of antibodies against HIV than white and Hispanic volunteers.
The full trial results are to be …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial